EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology

Sachindra Kumar, B Harish Kumar, Raksha Nayak, Samyak Pandey, Nitesh Kumar, K Sreedhara Ranganath Pai

Molecular Diversity · 2025-12 · 29 (6) · 5607-5633

DOI: 10.1007/s11030-024-11075-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, online erschienen am 09.01.2025. Verfasst von Sachindra Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal, 576104, India. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Molecular Dynamics Simulation, src Homology Domains, Network Pharmacology. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manipal Academy of Higher Education, Manipal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SH2 (Src Homology 2) domains play a crucial role in phosphotyrosine-mediated signaling and have emerged as promising drug targets, particularly in cancer therapy. STAT3 (Signal Transducer and Activator of Transcription 3), which contains an SH2 domain, plays a pivotal role in cancer progression and immune evasion because it facilitates the dimerization of STAT3, which is essential for their activation and subsequent nuclear translocation. SH2 domain-mediated STAT3 inhibition disrupts this binding, reduces phosphorylation of STAT3, and impairs dimerization. This study employed an in silico approach to screen potential natural compounds that could target the SH2 domain of STAT3 and inhibit its function. The phytomolecules (182455) were retrieved from the ZINC 15 database and were docked using various modes like HTVS, SP, and XP. The phytomolecules exhibiting higher binding affinity were selected. MM-GBSA was performed to determine binding free energy, and the QikProp tool was utilized to assess the pharmacokinetic properties of potential hit compounds, narrowing down the list of candidates. Molecular dynamics simulations, thermal MM-GBSA, and WaterMap analysis were performed on compounds that exhibited favorable binding affinities and pharmacokinetic characteristics. Based on docking scores and binding interactions, ZINC255200449, ZINC299817570, ZINC31167114, and ZINC67910988 were identified as potential STAT3 inhibitors. ZINC67910988 demonstrated superior stability in molecular dynamics simulation and WaterMap analysis. Furthermore, DFT was performed to determine energetic and electronic properties, and HOMO and LUMO sites were predicted for electronic structure calculation. Additionally, network pharmacology was performed to map the compounds’ interactions within biological networks, highlighting their multitarget potential. Compound-target networks elucidate the relationships between compounds and multiple targets, along with their associated pathways and help to minimize off-target effects. The identified lead compound showed strong potential as a STAT3 inhibitor, warranting further validation through in vitro and in vivo studies. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorMolecular Dynamics Simulationsrc Homology DomainsNetwork PharmacologyBiological ProductsMolecular Docking SimulationHumansProtein BindingDrug Evaluation, Preclinical

Stichwörter der Autor:innen

CancerMolecular dockingNetwork pharmacologyPhytochemicalSH2 domainSTAT3

Substanzen

STAT3 Transcription FactorBiological ProductsSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal, 576104, India.
  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, Vaishali, Bihar, 844102, India.
  • Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal, 576104, India. ksr.pai@manipal.edu.

Förderung

  • Manipal Academy of Higher Education, Manipal

Zitieren

APA

Kumar, S., Kumar, B. H., Nayak, R., Pandey, S., Kumar, N., & Pai, K. S. R. (2025). Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology. Molecular Diversity, 29(6), 5607-5633. https://doi.org/10.1007/s11030-024-11075-5

Vancouver

Kumar S, Kumar BH, Nayak R, Pandey S, Kumar N, Pai KSR. Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology. Molecular Diversity. 2025;29(6):5607-5633. doi:10.1007/s11030-024-11075-5

BibTeX
@article{Kumar2025,
  author = {Kumar, Sachindra and Kumar, B Harish and Nayak, Raksha and Pandey, Samyak and Kumar, Nitesh and Pai, K Sreedhara Ranganath},
  title = {Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology},
  journal = {Molecular Diversity},
  year = {2025},
  volume = {29},
  number = {6},
  pages = {5607--5633},
  doi = {10.1007/s11030-024-11075-5}
}
Kostenlos starten →